~~<i id='6C798C4E45'><strike id='6C798C4E45'><tt id='6C798C4E45'><pre id='6C798C4E45'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

author：comprehensive 2025-09-01 15:20:23 - browse：1

A sign of AdventHealth on its building in Orlando, Florida — coverage from STAT — Adobe

A lawsuit between a large hospital system and a dominant vendor that works for health insurance companies is getting a lot more heated — with one party calling the other an “economic parasite.”

The suit, between nonprofit hospital giant AdventHealth and MultiPlan, is now even attracting rare interest from the nation’s biggest hospital lobbyists.

The new, highly detailed legal filings also come right as MultiPlan and more than a dozen of the largest tax-exempt, nonprofit hospital systems are wooing investors at the J.P. Morgan Healthcare Conference. AdventHealth did not attend this year’s conference, but did so last year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： New warning issued for rebooking air travel after delays, cancellations

focus

explore

hotspot

explore

focus

3:08TravelerscheckthestatusoftheirflightsaheadoftheJuly4holidayweekendatRonaldReaganWashingtonNation

WSS

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

Stanford president to resign after investigation of research

Researchers separate signal from noise in heart wearable data

Community addresses injustice for Long Island mothers

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

Norman Reedus' Daryl Dixon

leisure time

leisure time

focus

ChatGPT in medicine: STAT answers readers' burning questions

Couple fighting to bring baby home from Mexico are finally reunited

In Memoriam: Notable people who died in 2023

States increasingly look to regulate hospital facility fees

Hollywood unions extend contract negotiations for actors

Make 'food is medicine' a key part of White House nutrition meeting

Medicare details structure of new drug price negotiation program

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Stanford president to resign after investigation of research

focus

'Reaching a detente': STAT's Helen Branswell on covering Covid

New case study details death in closely watched Alzhiemer's trial

TikTok cracks down on users posting about weight loss drugs

TikTok cracks down on users posting about weight loss drugs

Pfizer's Covid pill remains 89% effective in final analysis, company says

Plane’s emergency slide plummets from sky, hits Chicago home

explore

hotspot

explore

focus